Primary Care Case Study

Capsules 1–6

When Environmental Policy

Was Used to Justify an Unsafe Medication Switch

Capsule 1

When Environmental Policy

Was Used to Justify an Unsafe Medication Switch

The patient’s long‑established reliever inhaler was replaced without clinical review, despite documented medication sensitivities and explicit pharmacist warnings advising:

• “Do not switch to Salamol.”
• “Don’t switch to Avenor.”

The explanations provided by the practice included:

• “We need to save the planet.”
• “Ventolin is being discontinued.”
• “This is Local Government policy.”

None of these statements were accurate.

When the patient sought clarification, the Health Board confirmed:

• No enforced switch existed.
• Ventolin is not being discontinued.
• Patients already established on Ventolin may remain on it.
• Any switch must be clinically justified and practice‑led, not policy‑driven.
• The only relevant prescribing message relates to environmental guidance for new or one‑off prescriptions.

The Practice Manager later stated he had relied on a “quick chat” with a GP when repeating the discontinuation claim. This explanation — and the GP’s original statements — were inconsistent with the Health Board’s written clarification.

This discrepancy demonstrates a breakdown in clinical governance.

Clinicians are expected to:

• remain aware of current prescribing policy
• verify information before communicating it
• ensure that medication changes are clinically justified
• avoid presenting assumptions as mandates

In this case, inaccurate information circulated within the practice and was passed directly to the patient, resulting in an unsafe medication switch that contradicted both clinical guidance and Health Board policy.

Capsule 2

When Patient Consent Was Not Obtained for Student Presence

The practice’s own policy states:

“Patients will always be informed if a student will be present… If you are not comfortable you will be able to see a GP alone.”

This policy was not followed.

Across multiple consultations, the patient:

• was not informed that students would be present
• was not asked for consent
• was not offered the option to decline
• explicitly refused student presence
• had those refusals ignored
• was required to continue consultations with students present during sensitive and intimate discussions

These events represent:

• a breach of consent
• a breach of practice policy
• a breach of GMC standards
• a breach of trauma‑informed care principles

The impact was significant.

The presence of students — imposed without consent — destabilised consultations, disrupted clinical focus, and contributed to missed diagnostic opportunities. In one consultation, the GP incorrectly claimed the patient had been forewarned, despite no such communication being made.

Consent is not optional.

It is a fundamental requirement of safe, ethical clinical practice.

In this case, consent was not only absent — it was overridden.

This capsule demonstrates a systemic failure in respecting patient autonomy, privacy, and dignity, and highlights how repeated breaches of consent can directly affect clinical outcomes.

Capsule 2A

How Repeated Consent Breaches Destabilised Clinical Care

Across three separate consultations, students were present without prior notification, without consent, and despite the patient’s explicit refusals. These were not isolated misunderstandings but a repeated pattern that directly disrupted clinical assessment and contributed to missed diagnostic opportunities.

First consultation — destabilisation and loss of clinical purpose

• The patient waited almost an hour without being informed that students would be involved.
• Upon entering the room, several students were present.
• When the patient explained she had not been notified, the GP stated that student involvement was routine and implied the patient should have expected it.
• The GP did not ask the students to leave; they left voluntarily after recognising the patient’s discomfort.
• The GP’s visible frustration at their departure left the patient unable to continue the consultation.
• No assessment of the patient’s intended concerns took place.

Second and third consultations — repeated breaches with clinical consequences

Students were again present without prior notification. The patient’s refusals were ignored. These destabilised consultations resulted in:

• a dipstick that turned positive immediately but was not sent for laboratory analysis
• a later dipstick that was not shown to the patient and was discarded
• dismissal of concerns regarding previous confirmed infection
• minimisation of recurrent urinary symptoms
• refusal to initiate referral despite worsening dysphagia and reflux
• a statement from the GP that returning to report the new inhaler was ineffective would not be considered appropriate, discouraging help‑seeking

Systemic significance

These events represent repeated breaches of:

• consent
• practice policy
• GMC standards
• trauma‑informed care principles

The result was unsafe clinical environments, disrupted consultations, and missed diagnostic indicators. These were not minor procedural lapses — they directly affected diagnostic accuracy, continuity of care, and patient safety.

Capsule 3

When Recurrent Urinary Symptoms Were Minimized

Despite Positive Indicators

Across multiple consultations, the patient presented with longstanding urinary symptoms, including:

• recurrent UTIs
• repeated positive dipstick tests
• persistent microscopic haematuria
• increased frequency and urgency
• night‑time waking to urinate
• pelvic pressure and lower abdominal discomfort
• a previous urology finding of incomplete bladder emptying

Despite these indicators, the symptoms were repeatedly reframed as routine or non‑urgent.

During one consultation, a dipstick test turned positive immediately, but the sample was not sent for laboratory analysis. At a later consultation, a dipstick was performed but not shown to the patient; the test was discarded, and the patient was told it was “all clear” without explanation. These actions were inconsistent with the patient’s ongoing symptoms and her previous confirmed E. coli infection.

When the patient raised concerns about recurrence, the GP minimised the issue, stating that such infections were common in women. No follow‑up plan, safety‑netting advice, or repeat testing was offered. The patient’s previous positive culture, ongoing symptoms, and incomplete bladder emptying were not considered in the clinical assessment.

The patient also requested a referral to gastroenterology due to worsening reflux and dysphagia, but this was declined without investigation. The consultation remained narrowly focused, and the broader pattern of symptoms was not explored.

These events demonstrate a pattern of minimisation and missed opportunities for early investigation. Recurrent urinary symptoms — particularly when accompanied by positive indicators and previous abnormal findings — require structured assessment. In this case, the absence of follow‑up, documentation, and escalation contributed to delayed diagnosis and prolonged symptoms.

Capsule 4

When Positive Indicators Were Reassured Away

Instead of Investigated

Across multiple consultations, the patient presented with symptoms and findings that required structured investigation. Instead, clinically significant indicators were repeatedly reassured away, reframed as routine, or attributed to non‑clinical explanations without appropriate follow‑up.

Key missed indicators included:

• repeated positive dipstick reactions, including one that turned positive immediately
• persistent microscopic haematuria documented across several years
• a recent scan showing incomplete bladder emptying, minimised as “only millimetres” without context or follow‑up
• recurrent urinary symptoms consistent with infection or underlying pathology
• a previous confirmed E. coli culture
• worsening dysphagia and severe reflux despite treatment
• night‑time choking episodes and difficulty swallowing saliva
• upper abdominal and rib pain radiating front to back

Despite these findings, clinical responses remained limited to reassurance. Positive dipstick results were not sent for laboratory analysis, and later tests were discarded without explanation. The patient was told results were “all clear” without being shown the test or provided with safety‑netting advice.

Concerns about recurrent E. coli were minimised as “common in women,” and no repeat culture, imaging, or referral was initiated. The broader symptom pattern — including night‑time waking, pelvic pressure, and incomplete bladder emptying — was not considered in the assessment.

Similarly, when the patient requested a gastroenterology referral due to worsening dysphagia and reflux, the request was declined without investigation. Symptoms were reframed as non‑urgent despite their escalation and impact on daily functioning.

These responses demonstrate a pattern in which reassurance replaced clinical reasoning. Indicators that should have triggered structured assessment were instead normalised or dismissed. This approach contributed to delayed diagnosis, prolonged symptoms, and the eventual need for private investigation to obtain clarity.

Capsule 5

When Contradictory Explanations

Replaced Accurate Clinical Information

Across the course of this case, the patient received multiple conflicting explanations from the practice regarding medication changes, diagnostic decisions, and the availability of investigations. These contradictions created confusion, undermined trust, and contributed to delays in appropriate care.

The most significant contradictions involved the reliever inhaler switch. The patient was told:

• Ventolin was being discontinued
• The switch was required to “save the planet”
• The change was mandated by Local Government policy
• The practice had no choice but to switch all patients

When the patient sought clarification from the Health Board, the written response confirmed:

• Ventolin is not being discontinued
• No enforced switch exists
• Environmental guidance applies only to new or one‑off prescriptions
• Patients already established on Ventolin may remain on it
• Any switch must be clinically justified, not policy driven

The Practice Manager later explained that the patient’s original letter had been misdirected to a GP rather than to him, and that his understanding of the inhaler switch was based on a “quick chat” with that GP. This informal exchange was used to justify statements about environmental mandates and future discontinuation, despite these claims being inconsistent with Health Board policy and unsupported by prescribing guidance.

Similar contradictions occurred in relation to diagnostic findings. A scan showing incomplete bladder emptying was described as “only millimetres” without context or follow‑up, despite the patient’s ongoing symptoms and previous abnormal results. Positive dipstick reactions were acknowledged verbally but not documented or investigated, and later tests were discarded without explanation.

These inconsistencies created a pattern in which:

• inaccurate information was presented as fact
• assumptions were communicated as policy
• clinical findings were minimised without evidence
• reassurance replaced structured assessment
• the patient was left without a clear understanding of her health status

The cumulative effect was a breakdown in clinical governance. Accurate information was not verified before being communicated, and contradictory explanations circulated within the practice. This contributed directly to unsafe medication changes, missed diagnostic opportunities, and the patient’s eventual need to seek private assessment to obtain clarity.

Capsule 6

When Continuity Collapsed and Trauma‑Informed Care Was Absent

Over the course of this case, continuity of care deteriorated to the point that no single clinician held an overview of the patient’s history, symptom progression, or previous abnormal findings. The patient was seen by multiple different GPs, each of whom focused narrowly on the issue presented on the day, without reference to the broader clinical picture.

This lack of continuity contributed to:

• repeated minimisation of recurrent urinary symptoms
• inconsistent explanations for medication changes
• missed follow‑up on previous abnormal results
• contradictory interpretations of diagnostic findings
• absence of a coordinated management plan
• repeated reassurance in place of structured assessment

The patient’s longstanding history of trauma and complex needs was not acknowledged or incorporated into care planning. Despite clear indicators that a trauma‑informed approach was required — including difficulty with unexpected student presence, heightened anxiety during destabilised consultations, and previous negative healthcare experiences — no adjustments were made to support safe engagement.

Instead, the patient was repeatedly placed in situations that increased distress, including consultations with unfamiliar clinicians, unexpected observers, and inconsistent messaging. These factors contributed to the patient feeling unable to return when symptoms worsened, particularly after being told that reporting inhaler ineffectiveness would not be considered appropriate.

The absence of continuity meant that no clinician recognised the cumulative pattern of:

• recurrent infections
• persistent haematuria
• incomplete bladder emptying
• worsening dysphagia and reflux
• escalating abdominal and rib pain
• repeated positive dipstick reactions
• the impact of the medication switch on asthma control

Without a clinician overseeing the whole picture, significant indicators were treated as isolated events rather than components of a developing clinical pattern. This fragmentation of care directly contributed to delayed diagnosis, prolonged symptoms, and the patient’s eventual need to seek private assessment to obtain clarity.

Capsules 1–6 document the initial systemic failures that destabilised care: an unsafe medication switch, repeated breaches of consent, minimisation of symptoms, reassurance in place of investigation, and the collapse of continuity. Together, these events created the conditions in which further risks could develop unchecked.

Capsule 7 marks the point at which these unresolved issues began to escalate, revealing new contradictions, additional missed indicators, and the first signs that external intervention would become unavoidable.

Click 38c — Capsules 7–12

Design & Copyright Owner Maureen Booth-Martin (MBM) © All rights reserved